Literature DB >> 19706566

In utero valvuloplasty for pulmonary atresia with hypoplastic right ventricle: techniques and outcomes.

Wayne Tworetzky1, Doff B McElhinney, Gerald R Marx, Carol B Benson, Roland Brusseau, Donna Morash, Louise E Wilkins-Haug, James E Lock, Audrey C Marshall.   

Abstract

BACKGROUND: Prenatal intervention for fetuses with pulmonary atresia with an intact ventricular septum (PA/IVS) has the potential to alter right heart physiologic features in utero, facilitating right heart growth and improving the prospect of a biventricular outcome after birth.
METHODS: Since 2002, we have considered prenatal intervention for fetal PA/IVS in patients with (1) membranous pulmonary atresia, with identifiable pulmonary valve (PV) leaflets or membrane; (2) an intact or highly restrictive ventricular septum; and (3) right heart hypoplasia, with a tricuspid valve annulus z score of -2 or below and an identifiable but small right ventricle. Intervention was performed through direct cardiac puncture under ultrasound guidance, with percutaneous access or access through a limited laparotomy.
RESULTS: Ten fetuses underwent attempted balloon dilation of the PV in utero. The first 4 procedures were technically unsuccessful, and the most-recent 6 were technically successful. Compared with control fetuses with PA/IVS who did not undergo prenatal intervention and had univentricular outcomes after birth, the tricuspid valve annulus, right ventricle length, and PV annulus grew significantly more from midgestation to late gestation in the 6 fetuses who underwent successful interventions.
CONCLUSIONS: In utero perforation and dilation of the PV in midgestation fetuses with PA/IVS is technically feasible and may be associated with improved right heart growth and postnatal outcomes for fetuses with moderate right heart hypoplasia in midgestation. There is an important learning curve for this procedure, and much remains to be learned about the selection of appropriate fetuses for prenatal intervention.

Entities:  

Mesh:

Year:  2009        PMID: 19706566      PMCID: PMC4235279          DOI: 10.1542/peds.2008-2014

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  17 in total

1.  Invasive intrauterine treatment of pulmonary atresia/intact ventricular septum with heart failure.

Authors:  W Arzt; G Tulzer; M Aigner; R Mair; E Hafner
Journal:  Ultrasound Obstet Gynecol       Date:  2003-02       Impact factor: 7.299

2.  Fetal pulmonary valvuloplasty for critical pulmonary stenosis or atresia with intact septum.

Authors:  Gerald Tulzer; Wolfgang Arzt; Rodney C G Franklin; Pamela V Loughna; Rudi Mair; Helena M Gardiner
Journal:  Lancet       Date:  2002-11-16       Impact factor: 79.321

3.  Creation of an atrial septal defect in utero for fetuses with hypoplastic left heart syndrome and intact or highly restrictive atrial septum.

Authors:  Audrey C Marshall; Mary E van der Velde; Wayne Tworetzky; Carlen A Gomez; Louise Wilkins-Haug; Carol B Benson; Russell W Jennings; James E Lock
Journal:  Circulation       Date:  2004-06-28       Impact factor: 29.690

4.  Improved results with selective management in pulmonary atresia with intact ventricular septum.

Authors:  M Jahangiri; D Zurakowski; D Bichell; J E Mayer; P J del Nido; R A Jonas
Journal:  J Thorac Cardiovasc Surg       Date:  1999-12       Impact factor: 5.209

5.  Growth of the right ventricle after successful transcatheter pulmonary valvotomy in neonates and infants with pulmonary atresia and intact ventricular septum.

Authors:  C Ovaert; S A Qureshi; E Rosenthal; E J Baker; M Tynan
Journal:  J Thorac Cardiovasc Surg       Date:  1998-05       Impact factor: 5.209

6.  Prenatal diagnosis of right ventricular outflow tract obstruction with intact ventricular septum, and detection of ventriculocoronary connections.

Authors:  Y V Maeno; C Boutin; L K Hornberger; B W McCrindle; T Cavallé-Garrido; G Gladman; J F Smallhorn
Journal:  Heart       Date:  1999-06       Impact factor: 5.994

7.  Pulmonary atresia with intact ventricular septum: impact of fetal echocardiography on incidence at birth and postnatal outcome. UK and Eire Collaborative Study of Pulmonary Atresia with Intact Ventricular Septum.

Authors:  P E Daubeney; G K Sharland; A C Cook; B R Keeton; R H Anderson; S A Webber
Journal:  Circulation       Date:  1998-08-11       Impact factor: 29.690

8.  Outcomes in neonatal pulmonary atresia with intact ventricular septum. A multiinstitutional study.

Authors:  F L Hanley; R M Sade; E H Blackstone; J W Kirklin; R M Freedom; N C Nanda
Journal:  J Thorac Cardiovasc Surg       Date:  1993-03       Impact factor: 5.209

9.  Determinants of mortality and type of repair in neonates with pulmonary atresia and intact ventricular septum.

Authors:  David A Ashburn; Eugene H Blackstone; Winfield J Wells; Richard A Jonas; Frank A Pigula; Peter B Manning; Gary K Lofland; William G Williams; Brian W McCrindle
Journal:  J Thorac Cardiovasc Surg       Date:  2004-04       Impact factor: 5.209

10.  Balloon dilation of severe aortic stenosis in the fetus: potential for prevention of hypoplastic left heart syndrome: candidate selection, technique, and results of successful intervention.

Authors:  Wayne Tworetzky; Louise Wilkins-Haug; Russell W Jennings; Mary E van der Velde; Audrey C Marshall; Gerald R Marx; Steven D Colan; Carol B Benson; James E Lock; Stanton B Perry
Journal:  Circulation       Date:  2004-10-04       Impact factor: 29.690

View more
  20 in total

1.  Intrauterine Intervention of Pulmonary Atresia at 26th Gestational Week.

Authors:  Quan-Sheng Xing; Yue Sun; Gang Luo; Ai Zhang; Tao-Tao Chen; Si-Lin Pan
Journal:  Chin Med J (Engl)       Date:  2018-12-05       Impact factor: 2.628

2.  Prenatal Echocardiographic Predictors of Postnatal Management Strategy in the Fetus with Right Ventricle Hypoplasia and Pulmonary Atresia or Stenosis.

Authors:  Li Cao; Zhiyun Tian; Jack Rychik
Journal:  Pediatr Cardiol       Date:  2017-08-02       Impact factor: 1.655

Review 3.  Current status of fetal cardiac intervention.

Authors:  Doff B McElhinney; Wayne Tworetzky; James E Lock
Journal:  Circulation       Date:  2010-03-16       Impact factor: 29.690

4.  Rare copy number variants in a population-based investigation of hypoplastic right heart syndrome.

Authors:  Aggeliki Dimopoulos; Robert J Sicko; Denise M Kay; Shannon L Rigler; Charlotte M Druschel; Michele Caggana; Marilyn L Browne; Ruzong Fan; Paul A Romitti; Lawrence C Brody; James L Mills
Journal:  Birth Defects Res       Date:  2017-01-20       Impact factor: 2.344

Review 5.  Intrauterine surgery--choices and limitations.

Authors:  Anke Diemert; Werner Diehl; Peter Glosemeyer; Jan Deprest; Kurt Hecher
Journal:  Dtsch Arztebl Int       Date:  2012-09-21       Impact factor: 5.594

Review 6.  Percutaneous fetal cardiac interventions for structural heart disease.

Authors:  David N Schidlow; Wayne Tworetzky; Louise E Wilkins-Haug
Journal:  Am J Perinatol       Date:  2014-06-12       Impact factor: 1.862

Review 7.  Fetal cardiac interventions: an update of therapeutic options.

Authors:  Shi-Min Yuan
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Jul-Sep

8.  Reversible ductus arteriosus constriction due to maternal indomethacin after fetal intervention for hypoplastic left heart syndrome with intact/restrictive atrial septum.

Authors:  Melanie Vogel; Louise E Wilkins-Haug; Doff B McElhinney; Audrey C Marshall; Carol B Benson; Virginia Silva; Wayne Tworetzky
Journal:  Fetal Diagn Ther       Date:  2009-12-17       Impact factor: 2.587

9.  Fetal interventions for congenital heart disease in Brazil.

Authors:  Simone Rolim Fernandes Fontes Pedra; Cleisson Fábio Andrioli Peralta; Luciana Crema; Ieda Bosisio Jatene; Rodrigo Nieckel da Costa; Carlos Augusto Cardoso Pedra
Journal:  Pediatr Cardiol       Date:  2013-09-13       Impact factor: 1.655

Review 10.  Prenatal screening for structural congenital heart disease.

Authors:  Lindsey E Hunter; John M Simpson
Journal:  Nat Rev Cardiol       Date:  2014-03-25       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.